ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Nervgen Pharma Corporation

Nervgen Pharma Corporation (NGEN)

3,32
0,18
(5,73%)
Geschlossen 03 Januar 10:00PM

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

Current Price
3,32
Gebot
3,32
Fragen
3,35
Volumen
113.608
3,17 Tagesbereich 3,34
1,65 52-Wochen-Bereich 3,98
Marktkapitalisierung
Handelsende
3,14
Handelsbeginn
3,17
Letzte Trade
400
@
3.32
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
52.875
Ausgegebene Aktien
59.606.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-8,84
Gewinn pro Aktie (EPS)
-0,38
Erlöse
-
Nettogewinn
-22,38M

Über Nervgen Pharma Corporation

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
Hauptsitz
Vancouver, British Columbia, Can
Gegründet
-
Nervgen Pharma Corporation is listed in the Pharmaceutical Preparations sector of the TSX Venture Börse with ticker NGEN. The last closing price for Nervgen Pharma was $3,14. Over the last year, Nervgen Pharma shares have traded in a share price range of $ 1,65 to $ 3,98.

Nervgen Pharma currently has 59.606.000 shares in issue. The market capitalisation of Nervgen Pharma is $187,16 million. Nervgen Pharma has a price to earnings ratio (PE ratio) of -8.84.

NGEN Neueste Nachrichten

Life Science Investor Forum Agenda Announced for June 22nd

NEW YORK, June 20, 2023 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the Life Science Investor Forum...

NervGen Pharma’s NVG-291-R Demonstrates Significant Functional Repair From a Stroke 7 Days After Onset in Landmark Preclinical Study by University of Cincinnati and Case Western Reserve University

The independent peer-reviewed study showed improved memory as well as motor and sensory functions in rodents when treatment with NVG-291-R began 7 days after stroke onset There is currently no...

NervGen Pharma Announces Intent to Conduct Groundbreaking Spinal Cord Injury Clinical Trial in Exclusive Partnership With Shirley Ryan AbilityLab, #1-Ranked Hospital in Physical Medicine & Rehabilitation

Phase 1b/2a trial of NervGen’s lead compound, NVG-291, is based upon unprecedented, peer-reviewed animal studies demonstrating pronounced functional recovery from spinal cord injury “The ability...

NervGen Pharma Corp. Announces Public Offering

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, July 22, 2020 (GLOBE NEWSWIRE) -- NervGen Pharma Corp. (TSX-V: NGEN; OTCQX:...

American Stock Exchange to Trade Options on Four Securities

American Stock Exchange to Trade Options on Four Securities NEW YORK, Jan. 9 /PRNewswire/ -- The American Stock Exchange(R) (Amex(R)) will launch trading in options on Monday, January 12, 2004...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.26.410256410263.123.343.06301453.11447487CS
40.4616.08391608392.863.342.44597192.89286664CS
120.9741.27659574472.353.342.05528752.61572969CS
260.517.73049645392.823.342.05531852.74111858CS
520.7428.68217054262.583.981.65719802.58798029CS
1560.5921.61172161172.733.981.5439162.33239779CS
2601.3770.25641025641.953.980.8409102.28719858CS

NGEN - Frequently Asked Questions (FAQ)

What is the current Nervgen Pharma share price?
The current share price of Nervgen Pharma is $ 3,32
How many Nervgen Pharma shares are in issue?
Nervgen Pharma has 59.606.000 shares in issue
What is the market cap of Nervgen Pharma?
The market capitalisation of Nervgen Pharma is CAD 187,16M
What is the 1 year trading range for Nervgen Pharma share price?
Nervgen Pharma has traded in the range of $ 1,65 to $ 3,98 during the past year
What is the PE ratio of Nervgen Pharma?
The price to earnings ratio of Nervgen Pharma is -8,84
What is the reporting currency for Nervgen Pharma?
Nervgen Pharma reports financial results in CAD
What is the latest annual profit for Nervgen Pharma?
The latest annual profit of Nervgen Pharma is CAD -22,38M
What is the registered address of Nervgen Pharma?
The registered address for Nervgen Pharma is 1133 MELVILLE STREET, SUITE 3500, THE STACK, VANCOUVER, BRITISH COLUMBIA, V6E 4E5
What is the Nervgen Pharma website address?
The website address for Nervgen Pharma is nervgen.com/
Which industry sector does Nervgen Pharma operate in?
Nervgen Pharma operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
WEDWestaim Corporation
$ 31,15
(502,51%)
3,22k
ELBMElectra Battery Materials Corporation
$ 2,89
(344,62%)
37,59k
MTKMontauk Metals Inc
$ 0,01
(100,00%)
1.000
IBOUniversal Ibogaine Inc
$ 0,01
(100,00%)
1.000
VMY.HVoice Mobility International Inc
$ 0,01
(100,00%)
1.000
CPLCopper Lake Resources Ltd
$ 0,005
(-50,00%)
113k
RHCRoyal Helium Ltd
$ 0,02
(-33,33%)
1,46M
ULTUltra Lithium Inc
$ 0,01
(-33,33%)
29,43k
LBILions Bay Capital Inc
$ 0,02
(-33,33%)
2,5k
RECRecord Resources Inc
$ 0,025
(-28,57%)
73k
QUISQuisitive Technology Solutions Inc
$ 0,55
(46,67%)
8,65M
WGFWescan Goldfields Inc
$ 0,04
(100,00%)
5,97M
GPUSAlset AI Ventures Inc
$ 0,165
(-2,94%)
5,58M
MATEBlockmate Ventures Inc
$ 0,295
(3,51%)
3,48M
DMDataMetrex AI Limited
$ 0,005
(0,00%)
2,66M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock